End-stage liver disease (ESLD) also known as advanced liver disease is irreversible. While transplantation is a treatment option, many patients do not qualify for this type of treatment. Please join us for End-Stage Liver Disease: What to Know? What to Do? With Dr. Eric F. Martin.
Internal Medicine Physicians, Nephrologists, Physician Assistants, Residents, Advanced Practice Registered Nurses, Pharmacists and all other interested healthcare providers.
- Incorporate a stepwise approach to identifying the underlying cause of cirrhosis.
- Explain the pathophysiology behind portal hypertension and its consequences.
- Implement appropriate screening measures for gastroesophageal varices and hepatocellular carcinoma.
- Define acute-on-chronic liver failure (ACLF).
- Recognize Whether or when to refer for liver transplantation.
FACULTY AND DISCLOSURES:
Eric F. Martin, M.D.
Director, Transplant Hepatology Fellowship Program
Jackson Memorial Hospital/University of Miami Miller School of Medicine
Medical Director, Living Donor Liver Transplant, Miami Transplant Institute
Assistant Professor of Clinical Medicine
University of Miami Miller School of Medicine
Division of Hepatology
University of Miami Hospital/University of Miami Hospital and Clinics
Eric F. Martin, M.D., faculty for this educational event, indicated that he is a consultant for Gilead Sciences and DOVA Pharmaceuticals. He is also an adviser for DOVA Pharmaceuticals and on the speakers’ bureau for Gilead Sciences. All of the relevant financial relationships listed for this individual have been mitigated.
John Rubin, M.D., director for this educational event, owns stock in AstraZeneca and Bristol Myers Squibb. He has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for this individual have been mitigated.
Kenneth Rosenthal, M.D., FACG, moderator for this educational event, indicated that he is on the Speaker’s Bureau for AbbVie, Inc. All of the relevant financial relationships listed for this individual has been mitigated.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*
*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Disclosure Policy and Disclaimer
ACCREDITATION STATEMENTS AND CREDITS
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1 credit hour, CE Broker Course #20-855841, by the Florida Boards of Medicine, Podiatry, Dentistry, Osteopathic Medicine and Physician Assistants.
This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers. Baptist Health South Florida CE Broker Provider #50-182.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Florida Board of Athletic Training
- 1.00 General certificate of attendance
- 1.00 Florida Board of Dentistry
- 1.00 Florida Board of Dietitians
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy